Skp2 was a rate-limiting factor of the degradation of p27 protein (Carrano et al., 1999; Tsvetkov et al., 1999), and the Skp2-p27 axis controlled S phase entry, tumor stemness as well (Wang J. et al., 2021). This evidence concerns the gene CDKN1B and neoplasm.